2021
Outcomes of anus squamous cell carcinoma. Management of anus squamous cell carcinoma and recurrences
Marref I, Romain G, Jooste V, Vendrely V, Lopez A, Faivre J, Gerard J, Bouvier A, Lepage C. Outcomes of anus squamous cell carcinoma. Management of anus squamous cell carcinoma and recurrences. Digestive And Liver Disease 2021, 53: 1492-1498. PMID: 34193366, DOI: 10.1016/j.dld.2021.05.028.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaCell carcinomaAnal canalNet survivalBurgundy Digestive Cancer RegistryFive-year net survivalDigestive cancer registryCumulative recurrence ratePersistent active diseaseRisk of deathMultivariate survival analysisCumulative incidence functionCurative intentActive diseaseAbdominoperineal resectionAggressive managementCancer RegistryLocal inflammationRecurrence rateChemoradiotherapyCarcinomaRecurrenceRoutine practiceSurvival analysisRadiotherapy
2019
Net survival in recurrence-free colon cancer patients
Drouillard A, Bouvier A, Boussari O, Romain G, Manfredi S, Lepage C, Faivre J, Jooste V. Net survival in recurrence-free colon cancer patients. Cancer Epidemiology 2019, 61: 124-128. PMID: 31212224, DOI: 10.1016/j.canep.2019.06.001.Peer-Reviewed Original ResearchConceptsRecurrence-free patientsNet survivalColon cancerPopulation-based digestive cancer registryConditional net survivalDigestive cancer registryStage III diseasePeriods of remissionEstimation of prognosisPrimary colon cancerColon cancer patientsRelevant clinical informationCancer RegistryClinical presentationCancer patientsCancer populationSurvivors' qualityClinical informationPatientsStage IStage IIIStage IIDiagnosisFlexible parametric modelsSurvivalImpact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer
Willem H, Jooste V, Boussari O, Romain G, Bouvier A. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer. European Journal Of Cancer Prevention 2019, 28: 167-172. PMID: 29738323, DOI: 10.1097/cej.0000000000000450.Peer-Reviewed Original ResearchConceptsColorectal cancerMetachronous metastasesMetachronous groupNet survivalStage IV colorectal cancerStage IV patientsAge-standardized incidenceDiagnosis of metastasisProportion of cancersSynchronous groupSynchronous metastasesIV patientsCancer RegistryPrimary diagnosisColorectal adenocarcinomaEpidemiological studiesStage IIIStage IVRelevant cutoffsMetastasisStage IICancerFirst monthMonthsIncidenceTime-to-cure and cure proportion in solid cancers in France. A population based study
Romain G, Boussari O, Bossard N, Remontet L, Bouvier A, Mounier M, Iwaz J, Colonna M, Jooste V, Registries F. Time-to-cure and cure proportion in solid cancers in France. A population based study. Cancer Epidemiology 2019, 60: 93-101. PMID: 30933890, DOI: 10.1016/j.canep.2019.02.006.Peer-Reviewed Original ResearchConceptsTestis cancerCancer sitesThyroid cancerCure proportionFrench cancer registriesMost cancer sitesLarge national databaseHealthcare policy makersGynaecologic cancerYounger patientsCancer RegistryColorectal cancerSurvival cure modelUrinary tractCancer careDigestive cancersSolid cancersSkin melanomaSolid tumorsSmall intestineCancerPatientsNational databaseBreastCure
2018
A new approach to estimate time-to-cure from cancer registries data
Boussari O, Romain G, Remontet L, Bossard N, Mounier M, Bouvier A, Binquet C, Colonna M, Jooste V. A new approach to estimate time-to-cure from cancer registries data. Cancer Epidemiology 2018, 53: 72-80. PMID: 29414635, DOI: 10.1016/j.canep.2018.01.013.Peer-Reviewed Original ResearchConceptsPopulation-based cancer dataFlexible parametric cure modelsThyroid cancer patientsCancer registry dataParametric cure modelsCancer RegistryColorectal cancerCancer patientsPancreatic cancerCancer sitesBreast cancerRegistry dataCure modelAge groupsCancerCureDiagnosisSurvival frameworkCure fractionPatientsHealth insurance premiumsFrench networkSurvival time distributionYears